Login/Register
  • 中文
  • English

News

Genomics BioSci & Tech Eyes 2026 Growth Driven by Clinical LDTs and Overseas Expansion

Genomics BioSci & Tech (基米) reported record annual revenue of NT$708 million (+36.86% YoY) for 2025. General Manager Chiang Chun-chi noted that the company’s transition from a research-focused service to a clinical and industrial provider is yielding significant results.

Read more
Jan 13, 2026
NHI Implements Three New Policies with NT$370M Funding; Proton Therapy for Pediatric Cancer Included for the First Time
Jan 13, 2026
Lotus Pharma Surpasses NT$20 Billion Revenue Milestone, Retaining Top Spot in Biotech Sector
Jan 13, 2026
Grape King Reports 2025 Revenue Correction; Strong Momentum in OEM/ODM and Brain Health
Jan 13, 2026
Formosa Pharmaceuticals Grants Exclusive South Korean Commercialization Rights to Samil
Jan 13, 2026
Startup Update | Chronic Disease AI Smart Healthcare Platform Health2Sync to List on the Emerging Stock Market Today
Jan 12, 2026
Chlitina-KY Reports Recovery in Q4; AI-Driven "Focus on Store Health" to Drive 2026 Growth
Jan 12, 2026
PharmaEssentia’s Ropeg Hits Positive Top-line Results in North American ET Trial; Strong Response in First-Line Patients
Jan 12, 2026
Bora Pharmaceuticals Posts Steady 2025 Growth; CDMO Revenue (incl. inter-company) Surges 53.8%
Jan 12, 2026
Daiken Biomedical Hits Record Highs; Explosive 153% Growth in Japan Market

Most Watched

Recommended

Fungal Panel RUO
Applied BioCode
FOOTDISC Ergonomic seat cushion
GLOBAL ACTION INC
ELIXCYTE®
UnicoCell Biomed Co., Ltd.

Industry Watch

Read more